ZA90139B - Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles - Google Patents
Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindolesInfo
- Publication number
- ZA90139B ZA90139B ZA90139A ZA90139A ZA90139B ZA 90139 B ZA90139 B ZA 90139B ZA 90139 A ZA90139 A ZA 90139A ZA 90139 A ZA90139 A ZA 90139A ZA 90139 B ZA90139 B ZA 90139B
- Authority
- ZA
- South Africa
- Prior art keywords
- oxindoles
- heteroaryl
- acyl
- alkyl
- formula
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- -1 2-thiazolyl Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1989/000079 WO1990008145A1 (fr) | 1989-01-10 | 1989-01-10 | 1-heteroaryl-3-acyl-2-indoxyles anti-inflammatoires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA90139B true ZA90139B (en) | 1991-08-28 |
Family
ID=22214772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA90139A ZA90139B (en) | 1989-01-10 | 1990-01-09 | Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0378358B1 (fr) |
| JP (1) | JPH0692400B2 (fr) |
| KR (1) | KR920006785B1 (fr) |
| AT (1) | ATE96793T1 (fr) |
| AU (1) | AU616336B2 (fr) |
| CA (1) | CA2007655C (fr) |
| DE (1) | DE69004272T2 (fr) |
| DK (1) | DK0378358T3 (fr) |
| ES (1) | ES2060007T3 (fr) |
| FI (1) | FI92827C (fr) |
| HU (1) | HU215112B (fr) |
| IE (1) | IE62143B1 (fr) |
| IL (1) | IL92962A (fr) |
| NO (1) | NO179103C (fr) |
| NZ (1) | NZ232039A (fr) |
| PT (1) | PT92800B (fr) |
| WO (1) | WO1990008145A1 (fr) |
| ZA (1) | ZA90139B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2886541A1 (fr) * | 2013-12-19 | 2015-06-24 | Sanofi | Dérivés d'oxindole, leur préparation et leur utilisation thérapeutique pour traiter les troubles liés à l'AMPK |
| CN108456205B (zh) * | 2018-05-21 | 2021-06-04 | 深圳市众康动保科技有限公司 | 一种3,3二取代羟基吲哚化合物的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053613A (en) * | 1975-09-17 | 1977-10-11 | E. R. Squibb & Sons, Inc. | 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones |
| ATE63543T1 (de) * | 1984-02-07 | 1991-06-15 | Pfizer | 2-oxindolzwischenprodukte. |
| IN163263B (fr) * | 1984-02-07 | 1988-08-27 | Pfizer | |
| US4721712A (en) * | 1984-06-12 | 1988-01-26 | Pfizer Inc. | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
| HU203238B (en) * | 1984-08-24 | 1991-06-28 | Pfizer | Process for producing antiinflammatory tricyclic oxindole derivatives |
| US4690943A (en) * | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4686224A (en) * | 1984-10-31 | 1987-08-11 | Pfizer Inc. | Oxindole antiinflammatory agents |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
-
1989
- 1989-01-10 WO PCT/US1989/000079 patent/WO1990008145A1/fr not_active Ceased
- 1989-01-10 HU HU891086A patent/HU215112B/hu not_active IP Right Cessation
-
1990
- 1990-01-03 IL IL9296290A patent/IL92962A/en not_active IP Right Cessation
- 1990-01-08 NZ NZ232039A patent/NZ232039A/en unknown
- 1990-01-08 PT PT92800A patent/PT92800B/pt not_active IP Right Cessation
- 1990-01-09 ES ES90300229T patent/ES2060007T3/es not_active Expired - Lifetime
- 1990-01-09 ZA ZA90139A patent/ZA90139B/xx unknown
- 1990-01-09 AT AT90300229T patent/ATE96793T1/de not_active IP Right Cessation
- 1990-01-09 AU AU47816/90A patent/AU616336B2/en not_active Ceased
- 1990-01-09 EP EP90300229A patent/EP0378358B1/fr not_active Expired - Lifetime
- 1990-01-09 KR KR1019900000165A patent/KR920006785B1/ko not_active Expired
- 1990-01-09 DE DE90300229T patent/DE69004272T2/de not_active Expired - Fee Related
- 1990-01-09 IE IE7590A patent/IE62143B1/en not_active IP Right Cessation
- 1990-01-09 DK DK90300229.3T patent/DK0378358T3/da active
- 1990-01-10 JP JP2003286A patent/JPH0692400B2/ja not_active Expired - Fee Related
- 1990-01-12 CA CA002007655A patent/CA2007655C/fr not_active Expired - Fee Related
-
1991
- 1991-07-09 FI FI913324A patent/FI92827C/fi not_active IP Right Cessation
- 1991-07-09 NO NO912694A patent/NO179103C/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69004272T2 (de) | 1994-02-24 |
| EP0378358A1 (fr) | 1990-07-18 |
| KR900011762A (ko) | 1990-08-02 |
| FI913324A0 (fi) | 1991-07-09 |
| NO179103B (no) | 1996-04-29 |
| NO179103C (no) | 1996-08-07 |
| EP0378358B1 (fr) | 1993-11-03 |
| WO1990008145A1 (fr) | 1990-07-26 |
| FI92827C (fi) | 1995-01-10 |
| DK0378358T3 (da) | 1993-12-06 |
| NZ232039A (en) | 1991-07-26 |
| JPH0692400B2 (ja) | 1994-11-16 |
| HU215112B (hu) | 1998-12-28 |
| IE62143B1 (en) | 1994-12-14 |
| PT92800A (pt) | 1990-07-31 |
| KR920006785B1 (ko) | 1992-08-17 |
| HUT62292A (en) | 1993-04-28 |
| PT92800B (pt) | 1995-12-29 |
| IL92962A (en) | 1995-01-24 |
| JPH02270868A (ja) | 1990-11-05 |
| AU616336B2 (en) | 1991-10-24 |
| NO912694D0 (no) | 1991-07-09 |
| NO912694L (no) | 1991-07-09 |
| IE900075L (en) | 1990-07-10 |
| ATE96793T1 (de) | 1993-11-15 |
| AU4781690A (en) | 1990-07-19 |
| ES2060007T3 (es) | 1994-11-16 |
| CA2007655A1 (fr) | 1991-07-12 |
| DE69004272D1 (de) | 1993-12-09 |
| FI92827B (fi) | 1994-09-30 |
| CA2007655C (fr) | 1996-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3328499A (en) | Phthalazinone pde iii/iv inhibitors | |
| FI970246A7 (fi) | Dihydrobentsofuraanit | |
| NZ514037A (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders | |
| NO941698D0 (no) | Collagenaseinhibitor | |
| IL136359A0 (en) | Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same | |
| DE59806655D1 (de) | Pyranone, verfahren zu ihrer herstellung und verwendung | |
| IE900075L (en) | Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles | |
| AR020950A1 (es) | Compuestos de 3-(fenil sustituido)-5-tienil-1,2,4-triazolo con actividad contra la mosca blanca | |
| AU1192397A (en) | Substituted thiazolines and their use for controlling animal pests | |
| AU6085699A (en) | 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine | |
| AU6678094A (en) | 3-(hetero)aryloxy(thio) carboxylic acid derivatives, method of preparing them and intermediates used in their preparation | |
| HUT58052A (en) | Process for producing precursors of antiinflammatory 3-acyl-2-oxindole-1-carboxamides and pharmaceutical compositions comprising the compounds | |
| AU4781790A (en) | Anti-inflammatory 1-heteroaryloxindole-3-carboxamides | |
| EP0365194A3 (fr) | Prodrogues de 3-aryl-2-oxindole-1-carboxamide antiinflammatoires | |
| ATE263560T1 (de) | Neue verwendung von citreamicinen | |
| JPS536351A (en) | Stabilized rubber compositions | |
| NO890531L (no) | 3,4-dihydro-2-alkyl-3-okso-n-aryl-2h-(1)benzotieno(3,2-e)-1,2-tiazin-4-karboksamid-1,1-dioksyder. | |
| EP0058534A3 (fr) | Dérivés d'hexahydro-1,2,4-triazine-3,5-dione et leur application comme additifs d'alimentation | |
| KR927003511A (ko) | 5-리폭시게나제 억제제로서의 2-아릴메틸-1-나프톨 유도체의 에스테르 | |
| ITRM920124A0 (it) | Piastre refrattarie con inserti ceramici antiusura per macchine per colata continua di corpi piani sottili. |